What do family physicians need to know about caring for patients with Alzheimer’s disease (AD)? Family physicians are well positioned to spot the earliest signs of cognitive decline—and patients are more likely to discuss cognitive concerns with a clinician they know and trust. This session will provide you with the latest information regarding screening for AD-related dementia, diagnostic best practices, efficacy and safety data of recently approved and emerging therapeutic agents, and effective communication strategies. You will leave this 1-hour CME session better equipped to optimize care for your patients with AD.
Meeting Date:
Saturday, March 12, 2022
Friday, April 8, 2022
Are you frequently challenged by the task of early and accurate diagnosis of Alzheimer’s disease (AD) as a PCP? Are you keen to the possibility of collaboration with secondary care specialists to optimize early recognition and management of AD? Are you up to date on the latest developments and clinical pearls of Alzheimer’s research in order to tailor patient-specific approaches for AD? This live virtual meeting will examine these challenges and provide effective strategies to meet them head on.
This session will provide you with the latest information regarding the role of PCPs and their extended care team in early diagnosis of AD, effective methods to address racial and ethnic barriers to dementia-related care, and important clinical pearls to encourage collaboration among PCPs and secondary care specialists. In addition, learn the intricacies surrounding patient-specific management considerations, as well as the role of recently approved and emerging disease-modifying therapies for the management of AD.
The series will consist of 4 one-hour live, virtual programs held at select PrimaryCareNOW Meetings.
Meeting Date:
Thursday, December 16, 2021
Thursday, February 10, 2022
Thursday, March 17, 2022
Thursday, April 21, 2022
Women and Fabry Disease: What We Know, Why It Matters, and What Needs to Be Done
How does Fabry disease (FD) differ among women and men? Experts Dawn Laney, MS, CGC, CCRC, and Damara Ortiz, MD, discuss important clinical considerations for women with this lysosomal storage disorder in this 60-minute interactive live webcast. Gender-specific differences in the clinical presentation and diagnostic work-up for FD, current and emerging therapies in the management of FD, and the importance of elevating women in FD research are key points addressed in this activity. Mollie, an adult patient living with FD, shares her personal experience with this disorder as well.
The live one-hour webcast is scheduled to be held on Wednesday, March 16, 2022 from 1:00 PM – 2:00 PM Eastern
This educational activity will offer family physicians and other health care professionals an opportunity for detailed review of recent screening, diagnosis, and treatment recommendations described in clinical evidence and society guidelines, including the 2020 AACE/ACE Postmenopausal Osteoporosis Clinical Practice Guidelines Update. Additionally, the educational activity will focus on appropriately classifying patients with osteoporosis into a risk category based on patient-specific factors and subsequently determining the most effective treatment.
The series will consist of 4 one-hour live programs held at select AAFP State Chapter Meetings.
Locations:
Georgia
Virginia
North Carolina
Texas